These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 9549648)
1. Steady-state pharmacokinetics of zonisamide, an antiepileptic agent for treatment of refractory complex partial seizures. Kochak GM; Page JG; Buchanan RA; Peters R; Padgett CS J Clin Pharmacol; 1998 Feb; 38(2):166-71. PubMed ID: 9549648 [TBL] [Abstract][Full Text] [Related]
2. Population analysis of the dose-dependent pharmacokinetics of zonisamide in epileptic patients. Hashimoto Y; Odani A; Tanigawara Y; Yasuhara M; Okuno T; Hori R Biol Pharm Bull; 1994 Feb; 17(2):323-6. PubMed ID: 8205132 [TBL] [Abstract][Full Text] [Related]
3. Lack of pharmacokinetic interactions between steady-state zonisamide and valproic acid in patients with epilepsy. Ragueneau-Majlessi I; Levy RH; Brodie M; Smith D; Shah J; Grundy JS Clin Pharmacokinet; 2005; 44(5):517-23. PubMed ID: 15871637 [TBL] [Abstract][Full Text] [Related]
4. Disposition and safety of zonisamide after intravenous and oral single dose and oral multiple dosing in normal hound dogs. Boothe DM; Perkins J J Vet Pharmacol Ther; 2008 Dec; 31(6):544-53. PubMed ID: 19000278 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of zonisamide and drug interaction with phenobarbital in dogs. Orito K; Saito M; Fukunaga K; Matsuo E; Takikawa S; Muto M; Mishima K; Egashira N; Fujiwara M J Vet Pharmacol Ther; 2008 Jun; 31(3):259-64. PubMed ID: 18471148 [TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of zonisamide after oral administration in healthy Chinese volunteers. Qiu X; Dai Q; Sun F; Liu Y; Yang B; Xiang R; Yu M; Xiong L; Bi S; Lu W; Chen Y; Xia P Int J Clin Pharmacol Ther; 2016 May; 54(5):362-8. PubMed ID: 27007995 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of zonisamide; saturable distribution into human and rat erythrocytes and into rat brain. Nishiguchi K; Ohnishi N; Iwakawa S; Yagi J; Nakayama S; Takada S; Nakamura H; Yokoyama T; Okumura K J Pharmacobiodyn; 1992 Aug; 15(8):409-15. PubMed ID: 1479541 [TBL] [Abstract][Full Text] [Related]
8. [Age dependency of the serum concentration of zonisamide]. Ishizu T No To Hattatsu; 1993 May; 25(3):293-5. PubMed ID: 8517993 [No Abstract] [Full Text] [Related]
9. Zonisamide: pharmacokinetics, efficacy, and adverse events in children with epilepsy. Wallander KM; Ohman I; Dahlin M Neuropediatrics; 2014 Dec; 45(6):362-70. PubMed ID: 25133701 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of zonisamide following rectal administration to healthy dogs. Michaels JR; Hodshon AJ; Thomas WB; Boothe DM; Williams L Am J Vet Res; 2016 Dec; 77(12):1374-1380. PubMed ID: 27901384 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of single-dose rectal zonisamide administration in normal dogs. Brewer DM; Cerda-Gonzalez S; Dewey CW; Boothe D; Van Horne K J Vet Intern Med; 2015; 29(2):603-6. PubMed ID: 25818215 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and drug interactions with zonisamide. Sills G; Brodie M Epilepsia; 2007 Mar; 48(3):435-41. PubMed ID: 17319920 [TBL] [Abstract][Full Text] [Related]
13. Influence of coadministered antiepileptic drugs on serum zonisamide concentrations in epileptic patients: quantitative analysis based on suitable transforming factor. Fukuoka N; Tsukamoto T; Uno J; Kimura M; Morita S Biol Pharm Bull; 2003 Dec; 26(12):1734-8. PubMed ID: 14646181 [TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacology and therapeutic drug monitoring of zonisamide. Mimaki T Ther Drug Monit; 1998 Dec; 20(6):593-7. PubMed ID: 9853971 [TBL] [Abstract][Full Text] [Related]
15. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women. Griffith SG; Dai Y Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769 [TBL] [Abstract][Full Text] [Related]
16. Profile of once-daily zonisamide as monotherapy for treatment of partial seizures in adults. Mula M Drug Des Devel Ther; 2013; 7():397-402. PubMed ID: 23700365 [TBL] [Abstract][Full Text] [Related]
17. Pilot study of zonisamide (1,2-benzisoxazole-3-methanesulfonamide) in patients with refractory partial seizures. Sackellares JC; Donofrio PD; Wagner JG; Abou-Khalil B; Berent S; Aasved-Hoyt K Epilepsia; 1985; 26(3):206-11. PubMed ID: 3924586 [TBL] [Abstract][Full Text] [Related]
18. Dialyzability of the antiepileptic drug zonisamide in patients undergoing hemodialysis. Ijiri Y; Inoue T; Fukuda F; Suzuki K; Kobayashi T; Shibahara N; Takenaka H; Tanaka K Epilepsia; 2004 Aug; 45(8):924-7. PubMed ID: 15270757 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and toxicity of zonisamide in cats. Hasegawa D; Kobayashi M; Kuwabara T; Ohmura T; Fujita M; Orima H J Feline Med Surg; 2008 Aug; 10(4):418-21. PubMed ID: 18372205 [TBL] [Abstract][Full Text] [Related]
20. Lack of a clinically significant effect of zonisamide on phenytoin steady-state pharmacokinetics in patients with epilepsy. Levy RH; Ragueneau-Majlessi I; Garnett WR; Schmerler M; Rosenfeld W; Shah J; Pan WJ J Clin Pharmacol; 2004 Nov; 44(11):1230-4. PubMed ID: 15496640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]